(Tromsø 1. July 2016) Svein Lien, CEO of Biotec Pharmacon has purchased 20.000
shares at NOK 11,00 per share via his fully owned company Spiralen Industrier
AS. After this transaction holds Svein Lien and associates 530.262 shares and
160.000 options in Biotec Pharmacon.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

